Literature DB >> 18061318

Prevalence of hepatitis A virus risk factors in a very low endemic country, Switzerland.

Meichun Mohler-Kuo1, Robert Steffen, Matthias Bopp, R Jake Jacobs, Margot Mutsch.   

Abstract

We aimed to estimate the population-based lifetime exposure to guidelines-based hepatitis A virus (HAV) risk factors in a country model with very low HAV endemicity. A cross-sectional survey among randomly selected residents of Switzerland aged 20-60 years was performed assessing the HAV exposure risk according to the U.S. and the Swiss guidelines. The adjusted prevalence of lifetime exposure to HAV-associated risk exceeded 80% with travel being the most important risk factor. In addition, not only the HAV vaccination coverage was low but also lack of awareness was widespread. As projections indicate a further increase in travel volume resulting imported HAV infections with subsequent transmission among the resident population are a public health concern and a universal HAV vaccination strategy for HAV should be evaluated.

Entities:  

Mesh:

Year:  2007        PMID: 18061318     DOI: 10.1016/j.vaccine.2007.10.033

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  1 in total

1.  Antioxidant defense and oxidative stress in children with acute hepatitis A.

Authors:  Lidija Popovic-Dragonjic; Maja Jovanovic; Miodrag Vrbic; Ljiljana Konstantinovic; Velimir Kostic; Ivan Dragonjic
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.